Gene Synthesis Market by Method, Service, Application, End Use, and Region — Global Size Worth USD 8.39 Billion by 2033, Driven by Synthetic Biology Investments and Next-Gen DNA Assembly Technologies

Gene Synthesis Market: Detailed 2025 Overview

Executive Summary

The global market for gene synthesis dedicated to research use reached an estimated USD 2.42 billion in 2025, with projections indicating growth to USD 8.39 billion by 2033. This expansion is powered by a 16.8% CAGR, primarily driven by surging investments in synthetic biology and ongoing advances in gene synthesis methods. Supportive regulatory policies, government initiatives, and technological breakthroughs are fostering rapid market growth across key regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Market Drivers & Dynamics

  • Synthetic Biology Investments: Companies and institutions globally are heavily investing in the development and commercial application of synthetic genes, propelling market expansion.
  • Advancing Synthesis Methods: Technologies such as PCR-based, solid-phase, and chip-based DNA synthesis are making gene construction faster, cheaper, and more precise.
  • Regulatory & Government Support: Favorable biosafety laws and ethical standards facilitate safe and transparent gene synthesis research worldwide.
  • Expanding Applications: Gene synthesis is increasingly vital in gene and cell therapy development, vaccine research, protein engineering, genomics, and diagnostics.
  • Global Collaboration: Academic, government, and corporate collaborations are accelerating method development and broadening geographic reach.

Technology Trends & Innovations

Technological advances are rapidly reshaping service offerings and research potential:

  • Automation & AI: Enhanced precision and speed in designing gene sequences, reduced turnaround times, and lower risks of error or contamination.
  • High-Throughput Synthesis: Platforms supporting large-scale gene assembly are enabling faster results for biopharma, vaccine, and genomics research.
  • Next-Gen Synthesis Platforms: Semiconductor chips and enzymatic assembly methods allow cost-effective construction of lengthy DNA sequences with minimal wastage.
  • Digital Integration: Cloud-based bioinformatics tools and AI-driven analytics streamline workflows and optimize design efficiency.

Structural Overview & Services

The market features a mix of established players and emerging firms, with moderate merger and acquisition activity aimed at expanding technological capacity, global reach, and service portfolios.

  • Antibody DNA Synthesis: This service segment led the market in 2024, accounting for 61.48% of total revenue. Rapid production of antibodies through gene synthesis is integral to pharmaceutical, biotech, and diagnostics research.
  • Viral DNA Synthesis: Expected to experience the fastest CAGR of 19.7% through 2033, this segment is driven by the need for custom viral genomes to support functional studies and vaccine development.
  • Expanded Service Portfolios: Companies are continuously introducing new synthesis formats, tailored constructs, and optimized vectors to meet evolving research needs.

Applications & End Use Trends

  • Gene & Cell Therapy: This application represented the largest revenue share—58.27%—in 2024. Demand is increasing thanks to new therapy initiatives and adoption of synthetic genes in clinical and pre-clinical research.
  • Vaccine Development: Synthetic genes are critical for speeding up vaccine discovery, especially in mRNA and DNA-based solutions.
  • End Users: Academic and government research institutions accounted for 42.13% of market revenue in 2024, leveraging flexible and automated synthesis techniques for diverse studies. Contract research organizations are experiencing rapid growth due to increasing outsourcing practices.

Regional Highlights

North America

Leading market share (36.80% in 2024) thanks to robust biotechnology infrastructure, major industry players, and high research activity. The US market benefits from extensive innovation and facility expansion, such as GenScript’s automated synthesis center in New Jersey.

Europe

Growth is propelled by advanced R&D efforts, government funding, strong research collaborations, and a mature biotechnology sector. The UK and Germany lead in synthetic biology research and infrastructure.

Asia Pacific

The fastest-growing region (18.2% CAGR), driven by rising investment, expanding service infrastructure, and active market participants targeting China, Japan, Singapore, and India. GenScript’s launch of a Singapore facility in 2023 marks this momentum.

Middle East & Africa

Emerging market fueled by government initiatives in scientific research, new molecular labs, and partnerships with international organizations. Kuwait, Saudi Arabia, and the UAE stand out for their increasing biotechnology investments and development of genomic capabilities.

Key Industry Participants

The market features well-established giants and innovative new entrants, with ongoing collaboration and competition driving technological progress and expansion. Market leaders include:

  1. GenScript
  2. Azenta, Inc. (GENEWIZ)
  3. Boster Biological Technology
  4. Twist Bioscience
  5. ProteoGenix
  6. Biomatik
  7. ProMab Biotechnologies, Inc.
  8. Thermo Fisher Scientific, Inc.
  9. Integrated DNA Technologies, Inc. (Danaher)
  10. OriGene Technologies, Inc.

Report Methodology & Scope

  • Market Coverage: Includes revenue forecasts, segmentation by region, method, service, application, research phase, and end use.
  • Quantitative Data: Market values and CAGR from 2025 through 2033, with historical data benchmarks (2021–2024).
  • Global Reach: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, including detailed country coverage.

Frequently Asked Questions

Q: What is the market value for gene synthesis in 2025?
The market is estimated at USD 2.42 billion.

Q: What is the projected growth rate?
The compound annual growth rate (CAGR) is 16.8% between 2025 and 2033.

Q: Which region leads the global market?
North America, with a share of 36.80% in 2024, led the global market.

Q: Who are the main industry participants?
Key firms include GenScript, GENEWIZ (Azenta), Twist Bioscience, Boster Biological Technology, Thermo Fisher Scientific, and others.

Q: What factors drive industry growth?
Increasing investment in synthetic biology, technological advances in enzymatic synthesis, favorable regulations, and growing demand for rapid, customized genetic constructs.

Our Clients